Crioestaminal invests EUR 1m in new laboratory area based in Cantanhede, Portugal, to produce stem cell drugs, and prepares to enter Asia
Crioestaminal investe EUR 1m em nova área laboratorial de Cantanhede para produção de medicamentos com células estaminais, e prepara entrada na Ásia
Intel ID : 247358
|
||||
| Intel ID | 247358 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Crioestaminal
(31 Dec 2008) |
Revenue: EUR 6,56m EBITDA: EUR 3,41m People: 26 |
|
| Date |
 |
|
| Country |  |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.